Viewing StudyNCT00191672



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00191672
Status: COMPLETED
Last Update Posted: 2007-01-26
First Post: 2005-09-12

Brief Title: A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer
Sponsor:
Organization: Eli Lilly and Company